| Organoid models of human and mouse ductal pancreatic cancer SF Boj, CI Hwang, LA Baker, IIC Chio, DD Engle, V Corbo, M Jager, ... Cell 160 (1), 324-338, 2015 | 1776 | 2015 |
| Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer VP Balachandran, M Łuksza, JN Zhao, V Makarov, JA Moral, R Remark, ... Nature 551 (7681), 512-516, 2017 | 926 | 2017 |
| A revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas O Basturk, SM Hong, LD Wood, NV Adsay, J Albores-Saavedra, ... The American journal of surgical pathology 39 (12), 1730, 2015 | 739 | 2015 |
| Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an “intestinal” pathway of carcinogenesis in the pancreas NV Adsay, K Merati, O Basturk, C Iacobuzio-Donahue, E Levi, JD Cheng, ... The American journal of surgical pathology 28 (7), 839-848, 2004 | 505 | 2004 |
| The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly … O Basturk, Z Yang, LH Tang, RH Hruban, V Adsay, CM McCall, ... The American journal of surgical pathology 39 (5), 683-690, 2015 | 488 | 2015 |
| Multi-institutional validation study of the American Joint Commission on Cancer changes for T and N staging in patients with pancreatic adenocarcinoma PJ Allen, D Kuk, C Fernandez-del Castillo, O Basturk, CL Wolfgang, ... Annals of surgery 265 (1), 185, 2017 | 452 | 2017 |
| Secondary tumors of the pancreas: an analysis of a surgical and autopsy database and review of the literature NV Adsay, A Andea, O Basturk, N Kilinc, H Nassar, JD Cheng Virchows Archiv 444, 527-535, 2004 | 433 | 2004 |
| A practical approach to the classification of WHO grade 3 (G3) well-differentiated neuroendocrine tumor (WD-NET) and poorly differentiated neuroendocrine carcinoma (PD-NEC) of … LH Tang, O Basturk, JJ Sue, DS Klimstra The American journal of surgical pathology 40 (9), 1192-1202, 2016 | 356 | 2016 |
| Pancreatic cysts: pathologic classification, differential diagnosis, and clinical implications O Basturk, I Coban, NV Adsay Archives of pathology & laboratory medicine 133 (3), 423-438, 2009 | 342 | 2009 |
| Well-differentiated neuroendocrine tumors with a morphologically apparent high-grade component: a pathway distinct from poorly differentiated neuroendocrine carcinomas LH Tang, BR Untch, DL Reidy, E O'Reilly, D Dhall, L Jih, O Basturk, ... Clinical Cancer Research 22 (4), 1011-1017, 2016 | 317 | 2016 |
| Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases O Basturk, L Tang, RH Hruban, V Adsay, Z Yang, AM Krasinskas, ... The American journal of surgical pathology 38 (4), 437-447, 2014 | 258 | 2014 |
| Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are≥ 1.0 cm): clinicopathologic and … V Adsay, KT Jang, JC Roa, N Dursun, N Ohike, P Bagci, O Basturk, ... The American journal of surgical pathology 36 (9), 1279-1301, 2012 | 219 | 2012 |
| Overview of the 2022 WHO classification of neuroendocrine neoplasms G Rindi, O Mete, S Uccella, O Basturk, S La Rosa, LAA Brosens, S Ezzat, ... Endocrine Pathology 33 (1), 115-154, 2022 | 218 | 2022 |
| Pathologic evaluation and reporting of intraductal papillary mucinous neoplasms of the pancreas and other tumoral intraepithelial neoplasms of pancreatobiliary tract … V Adsay, M Mino-Kenudson, T Furukawa, O Basturk, G Zamboni, ... Annals of surgery 263 (1), 162-177, 2016 | 216 | 2016 |
| Tumor-infiltrating neutrophils in pancreatic neoplasia MD Reid, O Basturk, D Thirabanjasak, RH Hruban, DS Klimstra, P Bagci, ... Modern Pathology 24 (12), 1612-1619, 2011 | 204 | 2011 |
| Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies MD Reid, P Bagci, N Ohike, B Saka, IE Seven, N Dursun, S Balci, H Gucer, ... Modern pathology 28 (5), 686-694, 2015 | 199 | 2015 |
| Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies MD Reid, P Bagci, N Ohike, B Saka, IE Seven, N Dursun, S Balci, H Gucer, ... Modern pathology 28 (5), 686-694, 2015 | 199 | 2015 |
| Squamous cell and adenosquamous carcinomas of the gallbladder: clinicopathological analysis of 34 cases identified in 606 carcinomas JC Roa, O Tapia, A Cakir, O Basturk, N Dursun, D Akdemir, B Saka, ... Modern Pathology 24 (8), 1069-1078, 2011 | 198 | 2011 |
| Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate CM McCall, C Shi, TC Cornish, DS Klimstra, LH Tang, O Basturk, LJ Mun, ... The American journal of surgical pathology 37 (11), 1671, 2013 | 194 | 2013 |
| Real-time genomic profiling of pancreatic ductal adenocarcinoma: potential actionability and correlation with clinical phenotype MA Lowery, EJ Jordan, O Basturk, RN Ptashkin, A Zehir, MF Berger, ... Clinical Cancer Research 23 (20), 6094-6100, 2017 | 171 | 2017 |
Volkan AdsayKoc University School of Medicine Department of Pathology, Istanbul, TurkeyBestätigte E-Mail-Adresse bei kuh.ku.edu.tr
